SCHEMBL12264151

SCHEMBL12264151

Clc1ccccc1C(NCCCNC(c1ccccc1)(c1ccccc1)c1ccccc1Cl)(c1ccccc1)c1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNN4 O15554 5/20 0.47
KIF11 P52732 4/20 0.47
HTR2A P28223 2/20 0.40
HTR2C P28335 2/20 0.40
OPRK1 P41145 2/20 0.40
KCNH2 Q12809 2/20 0.40
ADRA1A P35348 1/20 0.40
DUT P33316 1/20 0.38
KCNA3 P22001 2/20 0.37
TSHR P16473 3/20 0.36
CHRM2 P08172 2/20 0.36
MAPT P10636 2/20 0.36
CYP3A4 P08684 2/20 0.36
DRD2 P14416 2/20 0.36
DRD4 P21917 2/20 0.36
DRD3 P35462 2/20 0.36
LMNA P02545 2/20 0.36
MEN1 O00255 1/20 0.36
SLC22A1 O15245 1/20 0.36
NR1I2 O75469 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12264150 0.93 KCNN4 (0.50) KCNN4KIF11HTR2AHTR2COPRK1
SCHEMBL4254994 0.86 KCNN4 (0.44) KCNN4KIF11HTR2AHTR2COPRK1
SCHEMBL12264133 0.80 KIF11 (0.68) KCNN4KIF11DUTTSHRMAPT
SCHEMBL14156837 0.80 HTR2A (0.40) KCNN4KIF11HTR2AHTR2COPRK1
SCHEMBL2223266 0.79 KCNN4 (0.44) KCNN4KIF11HTR2AHTR2COPRK1
SCHEMBL17929547 0.79 KIF11 (0.57) KCNN4KIF11HTR2AHTR2COPRK1
SCHEMBL17426858 0.79 KIF11 (0.36) KCNN4KIF11HTR2AHTR2COPRK1
SCHEMBL14156834 0.76 KIF11 (0.36) KCNN4KIF11HTR2AHTR2COPRK1
SCHEMBL191706 0.76 KCNN4 (0.52) KCNN4KIF11HTR2AHTR2COPRK1
SCHEMBL29262767 0.76 KCNN4 (0.61) KCNN4KIF11HTR2AHTR2COPRK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8026263-B2 Methods for inhibiting neoproliferative changes in blood vessel walls THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2011-09-27 US disclosed
US-8026263-B2 Methods for inhibiting neoproliferative changes in blood vessel walls THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2011-09-27 US disclosed
US-7235577-B1 Non-peptide inhibition of T-lymphocyte activation and therapies related thereto THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2007-06-26 US disclosed
US-7235577-B1 Non-peptide inhibition of T-lymphocyte activation and therapies related thereto THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2007-06-26 US disclosed